Interview Released with Novartis Ahead of Pre-Filled Syringes & Injectable Drug Devices Europe 2019

London, United Kingdom, November 28, 2018 –(PR.com)– SMi Group are delighted to have James Mellman, Device Manager, Novartis, Co-Chair the 11th annual conference and exhibition on Pre-Filled Syringes & Injectable Drug Devices when it returns to Central London on 16th and 17th January 2019.

James is a device manager for Novartis in Basel, Switzerland. His main responsibilities include developing primary packaging systems for combination products and supporting new technologies. He has worked on a multitude of injection device platforms including pre-filled syringes, needle safety devices, auto injectors, and patch injectors. He has also helped to build and implement a renovated CCIT strategy for the Novartis Group.

Before Novartis, James worked at Pfizer in their Devices Center of Excellence in Cambridge, UK (2008-2011) and Nutricia in their Advanced Medical Nutrition Division HQ in Amsterdam, NL (2011-2014). He received his PhD from the University of Florida in Materials Science & Engineering in 2007 specializing in biomaterials.

In the run-up to the event, they caught up with him to discuss current industry hurdles and the upcoming conference. From the answers provided it is apparent that the growing usage of prefilled syringes and technological advancements in auto-injectors are key factors driving the market today.

As well as Co-Chairing Pre-Filled Syringes Europe alongside Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT will also be leading an industry-led panel discussion with GSK, and MSD. The event spotlight on regulation will also include an exclusive keynote address from the MHRA.

Here is a snap shot of the interview:

What is your area of expertise within the Pre-filled Syringes market?
�My expertise comes from working at Novartis since 2014. I worked on a number of projects for both development and commercial products, and this has allowed me to get to know the issues, supply chain, and best practices in the field. A great interest of mine is evaluating compatibility between drug products and their delivery system.”

What do you hope to gain from this meeting?
“I hope to learn from the great work from others who are presenting as well as the discussions that follow.”

The full interview is available online in the event download centre.
SMi’s 11th annual 2018 Pre-Filled Syringes & Injectable Drug Devices Europe conference and exhibition will take place on 16th & 17th Jan at the Copthorne Tara Hotel, Kensington, London UK.

Further information including a detailed agenda and full speaker line-up is available at http://www.pre-filled-syringes.com/pr3

Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 688 / Email:
hsidhu@smi-online.co.uk

Sponsors of Pre-Filled Syringes Europe 2019 include:
Eveon, Fruh, Harro Hoefliger, Mitsubishi Gas Chemical, Mikron, Nemera, Nelson labs, Nipro PharmaPackaging, Owen mumford, PHC Corporation, Schott, Zeon, Zwick Testing Machines

For details email director Alia Malick at amalick@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk